All Stories

  1. Descemet's membrane endothelial keratoplasty with scraping without descemetorhexis (DMEK-SWD) in a failed penetrating keratoplasty
  2. Comparative efficacy of Nd : YAG laser peripheral iridotomy and surgical iridectomy in modulating perioperative subclinical inflammation after ...
  3. Corneal Stromal Thinning and Posterior Irregularity After DMEK: Clinical Observations and Biophysical Hypotheses
  4. Anterior Chamber Inflammation and Descemet Membrane Endothelial Keratoplasty
  5. Differential Diagnosis of Corneal Manifestations in Hypovitaminosis and Retinitis Pigmentosa
  6. Validation of a Deep Learning–Assisted Evaluation of Total Corneal Endothelial Cells Viability
  7. Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care
  8. Advanced imaging of corneal neovascularisation with a novel swept-source AS-OCTA system
  9. Atypical Endophthalmitis Following Artificial Corneal Endothelial Implantation
  10. Trypan blue-assisted iris cyst excision
  11. Evaluating the efficacy of postoperative topical antibiotics in cataract surgery: A systematic review and meta‐analysis
  12. Cataract surgery in megalocornea: A qualitative and quantitative evaluation of published literature
  13. Repeatability of Pentacam HR in Keratoconus According to Two Different Scan Protocols: 25-3D Scan and 50-Cornea Fine
  14. Suprachoroidal injection of triamcinolone acetonide as adjuvant to surgical treatment of epiretinal membrane
  15. Comparative Analysis of Tomographic Indicators Forecasting Decompensation in Fuchs Endothelial Corneal Dystrophy
  16. Life-threatening complications in ophthalmic surgery: a systematic review
  17. Corneal Artificial Endothelial Layer (EndoArt): Literature Review and Our Experience
  18. Off-Centered Descemet Membrane Endothelial Keratoplasty Grafts: Impact and Resolution
  19. Utilising Narrative Medicine to Identify Key Factors Affecting Quality of Life in Dry Eye Disease: An Italian Multicentre Study
  20. Natural history of cerebral visual impairment in children with cerebral palsy
  21. Preoperative Posterior Stromal Ripples as Predictive Biomarkers of Visual Recovery After Descemet Membrane Endothelial Keratoplasty
  22. Multimodal imaging and histopathological evaluation in silicone oil keratopathy
  23. The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment
  24. Corneal manifestations in bariatric surgery-related hypovitaminosis
  25. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
  26. Quality assurance in corneal transplants: Donor cornea assessment and oversight
  27. Topical Antiseptics in Minimizing Ocular Surface Bacterial Load Before Ophthalmic Surgery: A Randomized Controlled Trial
  28. Open-source, 3D printable IOL holder for detailed, smartphone-based anterior segment photography
  29. Double trouble in DMEK surgery: Learning experience and review of the literature
  30. DMEK surgical training: An instructional guide on various wet-lab methods
  31. DMEK F-marking complication: case report and literature review
  32. Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome
  33. Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol
  34. Antimicrobials and antiseptics: Lowering effect on ocular surface bacterial flora – A systematic review
  35. Artificial iris implantation in congenital aniridia: A systematic review
  36. Deep Learning Using Preoperative AS-OCT Predicts Graft Detachment in DMEK
  37. FGF-trapping hampers cancer stem-like cells in uveal melanoma
  38. Combined or sequential DMEK in cases of cataract and Fuchs endothelial corneal dystrophy—A systematic review and meta‐analysis
  39. A goat eye, wet lab model for training in Descemet membrane endothelial keratoplasty
  40. Incidence and management of early postoperative complications in lamellar corneal transplantation
  41. Role of Direct Supervision in the Learning Curve of Descemet Membrane Endothelial Keratoplasty Surgery
  42. Intraoperative OCT for Lamellar Corneal Surgery: A User Guide
  43. Predictability of the vault after implantable collamer lens implantation using OCT and artificial intelligence in White patient eyes
  44. Selective laser capsulotomy complications: Management and prevention
  45. Neurovisual profile in children affected by Angelman syndrome
  46. Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
  47. Surgical goniolens for tag identification and removal in DMEK surgery
  48. Allogeneic Solid Platelet-Rich Plasma for Persistent Epithelial Neurotrophic Defects: A Protocol and Pilot Study
  49. Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome
  50. COVID-19 and Clinically Isolated Syndrome: Coincidence or Causative Link? A 12-Month Follow-Up Case Report
  51. Comments on: Fine-needle diathermy for corneal vascularization
  52. Extended Overview of Ocular Phenotype with Recent Advances in Hypohidrotic Ectodermal Dysplasia
  53. Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade
  54. What empiric treatment should be given for suspected bacterial keratitis in Northern Italy?
  55. DMEK graft: One size does not fit all
  56. Myopia: Mechanisms and Strategies to Slow Down Its Progression
  57. COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion
  58. Visual and Refractive Outcomes Following Laser Blended Vision With Non-linear Aspheric Micro-anisometropia (PRESBYOND) in Myopic and Hyperopic Patients
  59. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives
  60. Age-Related Effects on the Spectrum of Cerebral Visual Impairment in Children With Cerebral Palsy
  61. Update on Suture Techniques in Corneal Transplantation: A Systematic Review
  62. An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
  63. SURGICAL OUTCOMES OF VITREOMACULAR TRACTION TREATED WITH FOVEAL-SPARING PEELING OF THE INTERNAL LIMITING MEMBRANE
  64. Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells
  65. Two-Year Changes in Corneal Spherical Aberration After Laser-Assisted In Situ Keratomileusis and Photorefractive Keratectomy in Regular and Wavefront-Guided Ablations
  66. Neurodevelopmental Profile in Children Affected by Ocular Albinism
  67. Early visual training and environmental adaptation for infants with visual impairment
  68. Risk factors for postoperative eye pain in patients with non-painful eye disease undergoing pars plana vitrectomy: the VItrectomy Pain (VIP) study
  69. A novel quantitative analysis method for idiopathic epiretinal membrane
  70. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
  71. VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
  72. Topography/wavefront-guided photorefractive keratectomy combined with crosslinking for the treatment of keratoconus: preliminary results
  73. Changes in pupillometry associated with dissipated energy during phacoemulsification
  74. Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes
  75. Effectiveness and Safety of Topical Chlorhexidine and Vitamin E TPGS in the Treatment of Acanthamoeba Keratitis: A Survey on 29 Cases
  76. Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform
  77. Effects of the first month of lockdown for COVID-19 in Italy: A preliminary analysis on the eyecare system from six centers
  78. FOVEA-SPARING VERSUS COMPLETE INTERNAL LIMITING MEMBRANE PEELING IN VITRECTOMY FOR THE TREATMENT OF MACULAR HOLES
  79. Pneumatic retinopexy preceded by drainage of subretinal fluid for the treatment of severe bullous retinal detachment
  80. PEELING OF THE INTERNAL LIMITING MEMBRANE WITH FOVEAL SPARING FOR TREATMENT OF DEGENERATIVE LAMELLAR MACULAR HOLE
  81. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  82. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  83. Ocular Refraction at Birth and Its Development During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy
  84. Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits
  85. Central Serous Chorioretinopathy: Pathogenesis and Management
  86. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
  87. EPIRETINAL MEMBRANE REMOVAL WITH FOVEAL-SPARING INTERNAL LIMITING MEMBRANE PEELING
  88. The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
  89. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
  90. Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?
  91. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications
  92. Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial
  93. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
  94. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study
  95. POOR CONCORDANCE BETWEEN NON-INVASIVE AND LOCALLY INVASIVE TECHNIQUES OF EVALUATION OF MICROVASCULAR MORPHOLOGY IN THE DETECTION OF HYPERTROPHIC REMODELING OF SMALL RESISTANCE ARTERIES
  96. Comparison between invasive and noninvasive techniques of evaluation of microvascular structural alterations
  97. ranibizumab and indomethacin in neovascular age-related macular degeneration
  98. Carotid stiffness is significantly correlated with wall-to-lumen ratio of retinal arterioles
  99. New Methods to Study the Microcirculation
  100. Neonatal Assessment Visual European Grid (NAVEG): Unveiling neurological risk
  101. ILM peeling in nontractional diabetic macular edema: review and metanalysis
  102. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
  103. [PP.09.17] REPRODUCIBILITY OF THE EVALUATION OF THE WALL TO LUMEN RATIO OF RETINAL ARTERIOLES WITH TWO DIFFERENT NON-INVASIVE APPROACHES
  104. Ocular fundus photography with a smartphone device in acute hypertension
  105. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension
  106. Heavy and standard silicone oil: intraocular inflammation
  107. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy
  108. Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice
  109. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans
  110. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
  111. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery
  112. Trace elements and diabetes: Assessment of levels in tears and serum
  113. Spectral-domain optical coherence tomography findings in idiopathic lamellar macular hole
  114. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment
  115. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface
  116. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia
  117. Relationship Between Different Subpopulations of Circulating CD4+T-lymphocytes and Microvascular Structural Alterations in Humans
  118. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio
  119. [PP.21.05] RELATIONSHIP BETWEEN MICROVASCULAR STRUCTURE AND T REGULATORY LYMPHOCYTES OF SMALL RESISTANCE ARTERIES
  120. [OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION
  121. Morphological and Functional Retinal Assessment in Epiretinal Membrane Surgery
  122. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety
  123. Zebrafish ( Danio rerio ) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
  124. REDUCTION OF VITREOUS PROSTAGLANDIN E2 LEVELS AFTER TOPICAL ADMINISTRATION OF INDOMETHACIN 0.5%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%
  125. Arteriolar Diameters in Glaucomatous Eyes with Single-Hemifield Damage
  126. Morphological and clinical characteristics of myopic posterior staphyloma in Caucasians
  127. Assessment of a smartphone-based camera for fundus imaging in animals
  128. INDICATIONS AND RESULTS OF A NEW L-SHAPED MACULAR BUCKLE TO SUPPORT A POSTERIOR STAPHYLOMA IN HIGH MYOPIA
  129. Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
  130. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
  131. TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH RANIBIZUMAB COMBINED WITH KETOROLAC EYEDROPS OR PHOTODYNAMIC THERAPY
  132. Efficacy and vitreous levels of topical NSAIDs
  133. PP.27.10
  134. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy
  135. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation
  136. Therapeutic Potential of Anti-Angiogenic Multitarget N,O -Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy
  137. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Diabetic Retinopathy
  138. Development of ocular hypertension secondary to tamponade with light versus heavy silicone oil: A systematic review
  139. A Novel Device to Exploit the Smartphone Camera for Fundus Photography
  140. Current Trends about Inner Limiting Membrane Peeling in Surgery for Epiretinal Membranes
  141. Diabetic Retinopathy: Vascular and Inflammatory Disease
  142. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy
  143. Effects of a Long-Term Treatment With Aliskiren or Ramipril on Structural Alterations of Subcutaneous Small-Resistance Arteries of Diabetic Hypertensive Patients
  144. Diameters and Wall-to-Lumen Ratio of Retinal Arterioles in Patients with Retinal Vein Occlusion Before and After Treatment with Dexamethasone Intravitreal Implants
  145. Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up
  146. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane
  147. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview
  148. Relationship of Wall-to-Lumen Ratio of Retinal Arterioles With Clinic and 24-Hour Blood Pressure
  149. Correlation between clinic and 24 hours blood pressure and wall-to-lumen ratio of retinal arterioles
  150. Infliximab
  151. Acute Dacryocystitis with Empyema of the Lacrimal Sac
  152. 5th International meeting on angiogenesis
  153. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
  154. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension
  155. Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation
  156. Quality of vision in patients implanted with aspherical and spherical intraocular lens: Intraindividual comparison
  157. Tamponade or Filling Effect: Changes of Forces in Myopic Eyes
  158. Heavy Silicone Oil and Intraocular Inflammation
  159. Etiopathogenesis and Therapy of Epithelial Ingrowth after Descemet’s Stripping Automated Endothelial Keratoplasty
  160. Some Physicochemical Remarks on Spontaneous Emulsification of Vitreal Tamponades
  161. Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies
  162. Macular Edema and Silicone Oil Tamponade
  163. Cognitive Dysfunction and Age-Related Macular Degeneration
  164. Clinical Analysis of Macular Edema with New Software for SD-OCT Imaging
  165. In vitro and ex vivo retina angiogenesis assays
  166. Neurotrophic Keratitis
  167. Ocular tissues and fluids oxidative stress in hares fed on verbascoside supplement
  168. Myopia onset and progression: can it be prevented?
  169. High doses of cobalt induce optic and auditory neuropathy
  170. Acute Dacryocystitis with Empyema of the Lacrimal Sac: Is Immediate Endoscopic Dacryocystorhinostomy Justified?
  171. Relationship between wall-to-lumen ratio of retimal arterioles and clinic and 24 hours blood pressure
  172. Aflibercept in wet AMD: specific role and optimal use
  173. Incidence rates of surgically treated rhegmatogenous retinal detachment among manual workers, non-manual workers and housewives in Tuscany, Italy
  174. A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration
  175. Familial Exudative Vitreoretinopathy caused by a Homozygous Mutation inTSPAN12in a Cystic Fibrosis Infant
  176. A novel ex vivo murine retina angiogenesis (EMRA) assay
  177. Corneal oedema and its medical treatment
  178. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection
  179. Novel aspects of Sjögren’s syndrome in 2012
  180. Recurrent Central Serous Chorioretinopathy after Peripheral Retinal Laser Photocoagulation: A Case Report
  181. INTRAVITREAL PEGAPTANIB SODIUM (MACUGEN) FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
  182. Central Retinal Vein Occlusion Treated with Ozurdex: A Case Report and Review of Literature
  183. Inflammation and Macular Oedema after Pars Plana Vitrectomy
  184. Erythropoietin and Diabetic Retinopathy
  185. Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
  186. Vitreous Mediators in Retinal Hypoxic Diseases
  187. Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks
  188. Proliferative Vitreoretinopathy after Eye Injuries: An Overexpression of Growth Factors and Cytokines Leading to a Retinal Keloid
  189. Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment
  190. TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
  191. P1.16 CORRELATION BETWEEN WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES AND CLINIC AND 24 HOURS BLOOD PRESSURE
  192. Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study
  193. Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
  194. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
  195. Identification of mRNAs and proteins specifically associated with transformation in ocular malignant melanoma cells
  196. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation
  197. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry
  198. Consensus on the diagnosis, treatment and follow-up of patients with age-related macular degeneration eligible for ranibizumab
  199. Defining reference values of trace elements in the tear film: Diagnostic methods and possible applications
  200. Reduction in retinal nerve fiber layer thickness in migraine patients
  201. Pseudo-Foster Kennedy syndrome in a young woman with meningioma infiltrating the superior sagittal sinus
  202. Proteomic Analyses of the Vitreous Humour
  203. Vitreous Analysis in the Management of Uveitis
  204. Mechanism of Inflammation in Age-Related Macular Degeneration
  205. 3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES
  206. Structural Alterations in Small Resistance Arteries in Obesity
  207. Retinal Angiomatosis and Cystoid Macular Oedema in Coganʼs Syndrome
  208. Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
  209. Predicting the risk of diabetic retinopathy in type 2 diabetic patients
  210. Genetic Predictors of Response to Photodynamic Therapy
  211. Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
  212. Isolated sphenoid inflammatory diseases associated with visual impairment: 15-year experience at a single institution
  213. Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
  214. Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
  215. Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia
  216. Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
  217. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
  218. INTRAVITREAL BEVACIZUMAB FOR TREATMENT-NAÏVE PATIENTS WITH SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
  219. Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up
  220. Endophthalmitis
  221. Multiple Strokes in a Newborn
  222. Selective Serotonin Reuptake Inhibitors: A Review of its Effects on Intraocular Pressure
  223. Intravitreal bevacizumab (Avastin®) injection for neovascular glaucoma: a survey on 23 cases throughout twelve-month follow-up
  224. Gonioscopic Findings in Patients with Type 1 Neurofibromatosis (Von Recklinghausen Disease)
  225. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
  226. Color Doppler Imaging of Ophthalmic Artery Blood Flow Velocity
  227. Diplopie Iatrogenique: Possible Responsabilite Professionelle
  228. Severe Corneoconjunctival Xerosis After Biliopancreatic Bypass for Obesity (Scopinaro's Operation)
  229. Cocaine-associated retinal vascular occlusion: Report of two cases
  230. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair